TCTR20190205002招募中4 期
Effects of Vitamin C, Vitamin D3, Coenzyme Q10 and antioxidant formula of different supplement forms on micronutrient, biomarker blood levels and quality of life.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- A
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1.Subjects aged ≥ 18 years who visit Vital-life wellness center for micronutrient level assessment and decide to receive either Vitamin C, Vitamin D3, CO-Q10 and antioxidant formula of HCK® or The original VTL supplement of Vitamin C, Vitamin D3, CO-Q10 and antioxidant or no supplement after discussion for possible treatment options with physician as usual practice
- •2.Subjects found to have low level of 25-(OH)D3/D2 (having 25-(OH)D3/D2 level 20-29 ng/ml) with the symptoms or feelings of low energy, lack of vitality or tiredness
- •3.Subjects who have not taken coenzyme Q10, vitamin C, vitamin D3, vitamin E, carotenoids, and flavonoids for at least 3 months and vitamin A for at least 6 months
- •4.Willing and able to comply with study procedure.
排除标准
- •1.Subjects with poorly controlled underlying diseases such as poor control of Blood
- •Pressure (systolic blood pressure > 180 mmHg or diastolic blood pressure > 110 mmHg), poor control of blood sugar (HbA1c > 7%).
- •2.Subjects with eGFR < 30 ml/min/1.73 m2
- •3.Female subjects who are pregnant or lactating, or plan to have children (a negative
- •serum or urine pregnancy test is required on the screening day for women of child-bearing potential).
- •4. Subjects with diseases that may interfere with supplement absorption e.g., patients
- •with malabsorption and bowel surgery.
- •5. Subjects using medication that may interfere with micronutrient levels such as acid
- •suppressants, antacids, antiepileptic drugs (i.e., phenobarbital, valproic acid,
- •carbamazepine, phenytoin), and antipsychotic drugs (i.e., tricyclic antidepressants and
- •haloperidol). However, subjects who stop using these medications for at least 1 month
- •prior to the enrollment can be included into the study.
- •6. Subjects with vitamin D deficiency or having underlying diseases that require
- •treatment with vitamin D such as osteoporosis and primary hyperparathyroidism
- •7. Subjects who is currently smoking.
- •8. Subjects with history of allergy to vitamins and supplements
研究者
相似试验
已完成
3 期
Role of antioxidants in newborns failing to initiate breathing at birthCTRI/2013/02/003379Government Medical College Bhavnagar95
尚未招募
3 期
Investigating the Effect of Vitamins E, C and D on Symptoms of Withdrawal SyndromeAnxiety and pain caused by drug withdrawal in addicted patients.Mental and behavioural disorders due to multiple drug use and use of other psychoactive substancesF19.3IRCT20200721048159N6Khoram-Abad University of Medical Sciences125
尚未招募
2 期
Treatment of distal radius fracturesFracture at wrist and hand level.Fracture at wrist and hand levelIRCT20211201053235N6Shahid Beheshti University of Medical Sciences60
已完成
3 期
Effect of vitamin supplementation on pulmonary fibrosis patientspulmonary fibrosis.Other interstitial pulmonary diseases with fibrosisIRCT201612202365N15Iran University of Medical Sciences36
已完成
不适用
Effects of a combined Vitamin D, Omega 3, Co-enzyme Q10, Zeaxanthin, Lutein and Astaxanthin supplement (Lester’s Oil) on Healthy peopleInflammationFatty acid profilesDiet and Nutrition - Other diet and nutrition disordersInflammatory and Immune System - Normal development and function of the immune systemACTRN12616001316493niversity of Auckland30